• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化外泌体:脓毒症性心肌病的一种潜在治疗策略。

Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy.

作者信息

Mao Lixia, Liu Songtao, Chen Yongxia, Huang Huiyi, Ding Fenghua, Deng Liehua

机构信息

Department of Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Outpatient Appointment Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

出版信息

Front Cardiovasc Med. 2024 Jun 28;11:1399738. doi: 10.3389/fcvm.2024.1399738. eCollection 2024.

DOI:10.3389/fcvm.2024.1399738
PMID:39006168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11239395/
Abstract

Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heart failure and carry a high mortality risk. Current treatments have limitations. Fortunately, engineered exosomes, created through bioengineering technology, may represent a potential new treatment method. These exosomes can both diagnose and treat septic cardiomyopathy, playing a crucial role in its development and progression. This article examines the strategies for using engineered exosomes to protect cardiac function and treat septic cardiomyopathy. It covers three innovative aspects: exosome surface modification technology, the use of exosomes as a multifunctional drug delivery platform, and plant exosome-like nanoparticle carriers. The article highlights the ability of exosomes to deliver small molecules, proteins, and drugs, summarizing several RNA molecules, proteins, and drugs beneficial for treating septic cardiomyopathy. Although engineered exosomes are a promising biotherapeutic carrier, they face challenges in clinical application, such as understanding the interaction mechanism with host cells, distribution within the body, metabolism, and long-term safety. Further research is essential, but engineered exosomes hold promise as an effective treatment for septic cardiomyopathy.

摘要

脓毒症性心肌病是脓毒症的一种危及生命的并发症,可导致急性心力衰竭并伴有高死亡风险。目前的治疗方法存在局限性。幸运的是,通过生物工程技术制造的工程化外泌体可能代表一种潜在的新治疗方法。这些外泌体既能诊断又能治疗脓毒症性心肌病,在其发生和发展中起着关键作用。本文探讨了利用工程化外泌体保护心脏功能和治疗脓毒症性心肌病的策略。它涵盖了三个创新方面:外泌体表面修饰技术、将外泌体用作多功能药物递送平台以及植物外泌体样纳米颗粒载体。文章强调了外泌体递送小分子、蛋白质和药物的能力,总结了几种对治疗脓毒症性心肌病有益的RNA分子、蛋白质和药物。尽管工程化外泌体是一种有前途的生物治疗载体,但它们在临床应用中面临挑战,例如了解与宿主细胞的相互作用机制、在体内的分布、代谢以及长期安全性。进一步的研究至关重要,但工程化外泌体有望成为治疗脓毒症性心肌病的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/1b90efb84ce7/fcvm-11-1399738-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/4dd3de8df643/fcvm-11-1399738-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/08b87dbb8c28/fcvm-11-1399738-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/1b90efb84ce7/fcvm-11-1399738-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/4dd3de8df643/fcvm-11-1399738-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/08b87dbb8c28/fcvm-11-1399738-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcdf/11239395/1b90efb84ce7/fcvm-11-1399738-g003.jpg

相似文献

1
Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy.工程化外泌体:脓毒症性心肌病的一种潜在治疗策略。
Front Cardiovasc Med. 2024 Jun 28;11:1399738. doi: 10.3389/fcvm.2024.1399738. eCollection 2024.
2
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.工程化外泌体用于药物递送:最新进展与临床应用。
Int J Nanomedicine. 2023 Dec 23;18:7923-7940. doi: 10.2147/IJN.S444582. eCollection 2023.
3
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.用于治疗应用的杂交外泌体、类外泌体纳米囊泡和工程化外泌体。
J Control Release. 2023 Jan;353:1127-1149. doi: 10.1016/j.jconrel.2022.12.027. Epub 2022 Dec 26.
4
The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System.外泌体作为药物递送系统载体的治疗潜力及临床意义
Pharmaceutics. 2022 Dec 21;15(1):21. doi: 10.3390/pharmaceutics15010021.
5
Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.肿瘤细胞外囊泡:癌症诊断和临床应用的可靠工具。
Cell Commun Signal. 2019 Jul 10;17(1):73. doi: 10.1186/s12964-019-0390-y.
6
Research Advances of Engineered Exosomes as Drug Delivery Carrier.工程外泌体作为药物递送载体的研究进展
ACS Omega. 2023 Nov 9;8(46):43374-43387. doi: 10.1021/acsomega.3c04479. eCollection 2023 Nov 21.
7
Advances in exosome therapies in ophthalmology-From bench to clinical trial.眼科外泌体疗法的进展——从实验台到临床试验。
Acta Ophthalmol. 2022 May;100(3):243-252. doi: 10.1111/aos.14932. Epub 2021 Jun 11.
8
Dual Behavior of Exosomes in Septic Cardiomyopathy.外泌体在脓毒症性心肌病中的双重作用
Adv Exp Med Biol. 2017;998:101-112. doi: 10.1007/978-981-10-4397-0_7.
9
Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention.释放外泌体在癌症研究中的潜力:诊断、治疗和预防的范式转变。
Pathol Res Pract. 2024 Mar;255:155214. doi: 10.1016/j.prp.2024.155214. Epub 2024 Feb 20.
10
Engineered exosomes from different sources for cancer-targeted therapy.不同来源的工程化细胞外囊泡用于癌症靶向治疗。
Signal Transduct Target Ther. 2023 Mar 15;8(1):124. doi: 10.1038/s41392-023-01382-y.

引用本文的文献

1
Roles and Therapeutic Targeting of Exosomes in Sepsis-Induced Cardiomyopathy.外泌体在脓毒症诱导的心肌病中的作用及治疗靶点
J Cell Mol Med. 2025 Apr;29(8):e70559. doi: 10.1111/jcmm.70559.
2
Exosomes and MicroRNAs: key modulators of macrophage polarization in sepsis pathophysiology.外泌体与微小RNA:脓毒症病理生理学中巨噬细胞极化的关键调节因子
Eur J Med Res. 2025 Apr 17;30(1):298. doi: 10.1186/s40001-025-02561-z.

本文引用的文献

1
Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity.吸入式细胞外囊泡传递 IL-12 mRNA 治疗肺癌并促进全身免疫。
Nat Nanotechnol. 2024 Apr;19(4):565-575. doi: 10.1038/s41565-023-01580-3. Epub 2024 Jan 11.
2
An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy.一种现成的用于肿瘤靶向治疗的小型细胞外囊泡纳米药物。
J Control Release. 2023 Dec;364:672-686. doi: 10.1016/j.jconrel.2023.11.013. Epub 2023 Nov 17.
3
Closer to The Heart: Harnessing the Power of Targeted Extracellular Vesicle Therapies.
更贴近心脏:利用靶向细胞外囊泡疗法的力量
Adv Biol (Weinh). 2024 Feb;8(2):e2300141. doi: 10.1002/adbi.202300141. Epub 2023 Nov 12.
4
Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease.Fe65 工程化神经元细胞外囊泡包裹的刻叶紫堇堿 B 改善阿尔茨海默病的认知和病理。
Signal Transduct Target Ther. 2023 Oct 23;8(1):404. doi: 10.1038/s41392-023-01657-4.
5
Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer.载 mRNA 的细胞外囊泡的适应性设计用于癌症的靶向免疫治疗。
Nat Commun. 2023 Oct 19;14(1):6610. doi: 10.1038/s41467-023-42365-5.
6
Cellular Uptake of Engineered Extracellular Vesicles: Biomechanisms, Engineered Strategies, and Disease Treatment.细胞摄取工程细胞外囊泡:生物力学、工程策略和疾病治疗。
Adv Healthc Mater. 2024 Jan;13(2):e2302280. doi: 10.1002/adhm.202302280. Epub 2023 Oct 26.
7
Current optimized strategies for stem cell-derived extracellular vesicle/exosomes in cardiac repair.目前用于心脏修复的干细胞衍生细胞外囊泡/外泌体的优化策略。
J Mol Cell Cardiol. 2023 Nov;184:13-25. doi: 10.1016/j.yjmcc.2023.09.006. Epub 2023 Oct 4.
8
Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery.工程化间充质干细胞衍生的细胞外囊泡构成了靶向药物递送的多功能平台。
J Control Release. 2023 Nov;363:235-252. doi: 10.1016/j.jconrel.2023.09.037. Epub 2023 Sep 28.
9
Neutrophil membrane-engineered Panax ginseng root-derived exosomes loaded miRNA 182-5p targets NOX4/Drp-1/NLRP3 signal pathway to alleviate acute lung injury in sepsis: experimental studies.中性粒细胞膜工程化人参根衍生外泌体负载的miRNA 182-5p靶向NOX4/Drp-1/NLRP3信号通路减轻脓毒症急性肺损伤:实验研究
Int J Surg. 2024 Jan 1;110(1):72-86. doi: 10.1097/JS9.0000000000000789.
10
Orally-Delivered, Cytokine-Engineered Extracellular Vesicles for Targeted Treatment of Inflammatory Bowel Disease.口服给药的细胞因子工程化细胞外囊泡用于炎症性肠病的靶向治疗
Small. 2023 Dec;19(50):e2304023. doi: 10.1002/smll.202304023. Epub 2023 Sep 20.